Beone Medicines USA, INC (Formerly Beigene USA, INC.)
Based in MA
🤖
AI Overview
With $3.5M in lobbying spend across 24 quarterly filings, Beone Medicines USA, INC (Formerly Beigene USA, INC.) is a significant lobbying presence. Their lobbying covers 7 issue areas. Active from 2020 to 2025.
$3.5M
Total Spend
6
Years Active
1
Firms Hired
2
Lobbyists Deployed
7
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $120K |
| 2021 | $320K |
| 2022 | $510K |
| 2023 | $700K |
| 2024 | $910K |
| 2025 | $930K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Trade, Manufacturing, Health Issues, Financial and 2 more
- •Support first U.S. product launch and efforts to enhance company profile/reputation; issues related to general business operations.
Related Analysis
Related Investigations
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Follow the Money
Tracking lobbying dollars through the financial system.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.